Rejuvenation Technologies
PrivateLast Round
Grant
Aug 1, 2024
Total Funding Raised
$17.83M
Company Overview
Rejuvenation Technologies is a biotechnology company specializing in regenerative medicine through the development of a telomere extender that enhances telomerase activity in cells to combat age-related diseases and conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rejuvenation Technologies Comps
Public and private peers based on sector, stage, and business model.
Rejuvenation Technologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 1, 2024 | ||||
| Grant | Jul 26, 2024 | ||||
| Seed | Sep 6, 2023 | ||||
| Grant | Jan 26, 2023 | ||||
| Grant | Sep 22, 2022 |
Rejuvenation Technologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Khosla Ventures | Seed |
| NIH RADx | Grant |
| Asymmetry Ventures | Seed |
| Y Combinator | Seed |
| National Center for Advancing Translational Sciences | Grant |
Rejuvenation Technologies Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Rejuvenation Technologies's valuation, stock price, and market status.
